Muhammad Saeed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhammad Saeed has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Asif Jan
Department of Pharmacy University of Peshawar KP Pakistan
1 shared publication Hamayun Khan
Islam College of Pharmacy, Gujranwala, Punjab, Pakistan
1 shared publication- Haroon Khan
Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan
1 shared publication - Irfan Ullah
Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Pakistan
1 shared publication Muhammad Shahid
Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Pakistan
1 shared publicationRani Akbar
Adul Wali Khan University Mardan, Pakistan
1 shared publication
Latest Publications
- Open Access
- 10 May 2023
- Published by Journal of the ASEAN Federation of Endocrine Societies (JAFES) in Journal of the ASEAN Federation of Endocrine Societies
- Vol. 38 (S1) , 48-54
Evaluation of Type 2 Diabetes Risk Variants (Alleles) in the Pashtun Ethnic Population of Pakistan
Objective. To evaluate the Type 2 Diabetes (T2D) risk variants in the Phastun ethnic population of Khyber Pakhtunkhwa using the nascent whole-exome sequencing (WES) to better understand the pathogenesis of this complex polygenic disorder. Methodology. A total of 100 confirmed patients with T2D of Pashtun ethnicity were included in the study, DNA was extracted from whole blood samples, and paired-end libraries were prepared using the Illumina Nextera XT DNA library kit carefully following the manufacturer’s instructions. Illumina HiSeq 2000 was used to obtain sequences of the prepared libraries followed by bioinformatics data analysis. Results. A total of n=11 pathogenic/likely pathogenic varinats were reported in the CAP10, PAX4, IRS-2, NEUROD1, CDKL1 and WFS1. Among the reported variants CAP10/rs55878652 (c.1990-7T>C; p.Leu446Pro) and CAP10/ rs2975766 (c.1996A>G; p.Ile666Val) identified were novel, and have not yet been reported for any disease in the database. The variants CAP10/rs7607759 (c.1510A>G, p.Thr504Ala), PAX4/rs712701 (c.962A>C; p.His321Pro), PAX4/rs772936097 (c.748-3delT; p.Arg325Trp), IRS-2/rs1805097 (c.3170G>A; p.Gly1057Asp), NEUROD1/rs1801262 (c.133A>G; p.Thr45Ala), CDKL1/rs77152992 (c.1226C>T; p.Pro409Leu), WFS1/rs1801212 (c.997G>A; p.Val333Ile), WFS1/rs1801208 (c.1367G>A; p.Arg456His), and WFS1/rs734312 (c.1832G>A; p.Arg611His) are previously identified in other ethnic populations. Our study reconfirms the associations of these variants with T2D in Pakistani Pashtun population. Conclusion. In-silico analysis of exome sequencing data suggest a statistically substantial association of all (n=11) identified variants with T2D in the Pashtun ethnic population. This study may serve as a foundation for performing future molecular studies aimed at unraveling T2D associated genes.
- 10 May 2023
- Published by Journal of the ASEAN Federation of Endocrine Societies (JAFES) in Journal of the ASEAN Federation of Endocrine Societies
- Vol. 38 (S1) , 48-54
Open AccessEvaluation of Type 2 Diabetes Risk Variants (Alleles) in the Pashtun Ethnic Population of Pakistan
Objective. To evaluate the Type 2 Diabetes (T2D) risk variants in the Phastun ethnic population of Khyber Pakhtunkhwa using the nascent whole-exome sequencing (WES) to better understand the pathogenesis of this complex polygenic disorder. Methodology. A total of 100 confirmed patients with T2D of Pashtun ethnicity were included in the study, DNA was extracted from whole blood samples, and paired-end libraries were prepared using the Illumina Nextera XT DNA library kit carefully following the manufacturer’s instructions. Illumina HiSeq 2000 was used to obtain sequences of the prepared libraries followed by bioinformatics data analysis. Results. A total of n=11 pathogenic/likely pathogenic varinats were reported in the CAP10, PAX4, IRS-2, NEUROD1, CDKL1 and WFS1. Among the reported variants CAP10/rs55878652 (c.1990-7T>C; p.Leu446Pro) and CAP10/ rs2975766 (c.1996A>G; p.Ile666Val) identified were novel, and have not yet been reported for any disease in the database. The variants CAP10/rs7607759 (c.1510A>G, p.Thr504Ala), PAX4/rs712701 (c.962A>C; p.His321Pro), PAX4/rs772936097 (c.748-3delT; p.Arg325Trp), IRS-2/rs1805097 (c.3170G>A; p.Gly1057Asp), NEUROD1/rs1801262 (c.133A>G; p.Thr45Ala), CDKL1/rs77152992 (c.1226C>T; p.Pro409Leu), WFS1/rs1801212 (c.997G>A; p.Val333Ile), WFS1/rs1801208 (c.1367G>A; p.Arg456His), and WFS1/rs734312 (c.1832G>A; p.Arg611His) are previously identified in other ethnic populations. Our study reconfirms the associations of these variants with T2D in Pakistani Pashtun population. Conclusion. In-silico analysis of exome sequencing data suggest a statistically substantial association of all (n=11) identified variants with T2D in the Pashtun ethnic population. This study may serve as a foundation for performing future molecular studies aimed at unraveling T2D associated genes.
- Open Access
- 7 July 2018
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 13 (3) , 222-230
Nephroprotective effect of Berberis baluchistanica against gentamicin-induced nephrotoxicity in rabbit
The present study was conducted to explore the protective effect of B. baluchistanica against gentamicin-induced renal toxicity in rabbits. Phytochemical investigations lead to the isolation of berberine and palmatine. The crude hydro-methanolic extract at various doses (100, 200 and 300 mg/kg body weight) elicited strong nephroprotective effects by restoring various biomarkers which were deranged by gentamicin such as creatinine, urea, serum uric acid levels (p<0.001) in plasma and urine output creatinine clearance, urinary protein and γ-glutamyl transferase level (p<0.001) in urine in a dose dependent manner. The mediators involved in oxidative stress such malondialdehyde, reduced glutathione, glutathione peroxidase, and catalase levels were significantly (P˂0.05-0.001) modulated in kidney tissue homogenate. Correspondingly, there is a significant (P<0.05) recovery in kidney weight and % loss in body weight compare to GM group. From these results, it is possible that B. baluchistanica exhibited protective effect mediated through the presence of berberine and palmatine. Video Clip of Methodology: Histopathology: 7 min 24 sec Click to watch
- 7 July 2018
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 13 (3) , 222-230
Open AccessNephroprotective effect of Berberis baluchistanica against gentamicin-induced nephrotoxicity in rabbit
The present study was conducted to explore the protective effect of B. baluchistanica against gentamicin-induced renal toxicity in rabbits. Phytochemical investigations lead to the isolation of berberine and palmatine. The crude hydro-methanolic extract at various doses (100, 200 and 300 mg/kg body weight) elicited strong nephroprotective effects by restoring various biomarkers which were deranged by gentamicin such as creatinine, urea, serum uric acid levels (p<0.001) in plasma and urine output creatinine clearance, urinary protein and γ-glutamyl transferase level (p<0.001) in urine in a dose dependent manner. The mediators involved in oxidative stress such malondialdehyde, reduced glutathione, glutathione peroxidase, and catalase levels were significantly (P˂0.05-0.001) modulated in kidney tissue homogenate. Correspondingly, there is a significant (P<0.05) recovery in kidney weight and % loss in body weight compare to GM group. From these results, it is possible that B. baluchistanica exhibited protective effect mediated through the presence of berberine and palmatine. Video Clip of Methodology: Histopathology: 7 min 24 sec Click to watch